Aetna is able to resume marketing and enrollment for its Medicare products, as the Centers for Medicare & Medicaid Services has lifted its sanctions, according to an Aetna news release.
CMS originally sanctioned Aetna due to improper administration of the Medicare drug benefit in the plan's national standalone prescription drug plan and its 25 Medicare Advantage prescription drug contracts, according to an April 2010 CMS news release.
Click here to read the full story in Becker's ASC Review about Aetna and CMS.
CMS originally sanctioned Aetna due to improper administration of the Medicare drug benefit in the plan's national standalone prescription drug plan and its 25 Medicare Advantage prescription drug contracts, according to an April 2010 CMS news release.
Click here to read the full story in Becker's ASC Review about Aetna and CMS.